Pernix Therapeutics Holdings, Inc.
PTX
PTX was delisted on the 4th of March, 2019.
45 hedge funds and large institutions have $26.4M invested in Pernix Therapeutics Holdings, Inc. in 2013 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 20 increasing their positions, 11 reducing their positions, and 4 closing their positions.
82% more repeat investments, than reductions
Existing positions increased: 20 | Existing positions reduced: 11
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 4
2% less funds holding
Funds holding: 46 → 45 (-1)
24% less capital invested
Capital invested by funds: $34.9M → $26.4M (-$8.49M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FCAM
F&C Asset Management
Edinburgh, Scotland,
United Kingdom
|
+$1.11M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$342K |
| 3 |
State Street
Boston,
Massachusetts
|
+$215K |
| 4 |
Northern Trust
Chicago,
Illinois
|
+$185K |
| 5 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$171K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACM
Argent Capital Management
St Louis,
Missouri
|
-$976K |
| 2 |
Adage Capital Partners
Boston,
Massachusetts
|
-$932K |
| 3 |
CCM
Cadence Capital Management
Boston,
Massachusetts
|
-$314K |
| 4 |
First Trust Advisors
Wheaton,
Illinois
|
-$53K |
| 5 |
Morgan Stanley
New York
|
-$42K |
PTX Hedge Fund Activity: Q3 2013 in Review
45 of the 3,096 institutional investors tracked by Wall St. Rank reported a position in Pernix Therapeutics Holdings, Inc. (PTX) for Q3 2013, worth a combined $26.4M — down 24% from $34.9M a quarter earlier.
Fund positioning in PTX was balanced in Q3 2013: 4 funds opened new positions, 4 closed out, 20 added to existing stakes and 11 trimmed.
The largest buyer was F&C Asset Management, adding an estimated $1.11M. The largest seller was Argent Capital Management, exiting entirely with an estimated $976K sold.
- 45 institutional investors held Pernix Therapeutics Holdings, Inc. (PTX) as of Q3 2013, down from 46 in Q2 2013.
- Funds reported $26.4M of Pernix Therapeutics Holdings, Inc. stock for Q3 2013, down 24% quarter-over-quarter.
- 4 funds opened new Pernix Therapeutics Holdings, Inc. positions in Q3 2013 and 4 closed out, a net change of 0 holders.
- The largest Pernix Therapeutics Holdings, Inc. buyer in Q3 2013 was F&C Asset Management, an estimated $1.11M added.
- The largest Pernix Therapeutics Holdings, Inc. seller in Q3 2013 was Argent Capital Management, an estimated $976K sold.
Based on aggregated 13F filings for Q3 2013.